ReviewAnnals of laboratory medicine2022
Current State of Blood Management Services in Korea.
Review in Annals of laboratory medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 27 citations in OpenAlex.
- A Nationwide Study on Pretransfusion Testing for 10 Years in Korea Using Health Insurance Review and Assessment Claims Data.Journal of Korean medical science · 2026Article
- Estimated blood storage requirements for a North Korean invasion of South Korea and South Korea's preparedness.Journal of trauma and injury · 2025Article
- Complement Activation and Hemolysis in Non-human Primates Following Transfusion of Genetically Modified Pig Red Blood Cells.Annals of laboratory medicine · 2025Article
- Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases.Journal of nanobiotechnology · 2025Review
- Factors regarding blood donation willingness and preferences toward feedback between first-time donors and repeat donors in China: a cross-sectional survey.Frontiers in medicine · 2025Article
- Optimizing the Hospital Blood Bank Stock in Korea: A Comparative Analysis of the Uniform 5-Day Stock Index and a Novel Blood Stock Index.Annals of laboratory medicine · 2024Article
- Prediction of Mid-term Platelet Transfusion in Stable Trauma Patients Using Rotational Thromboelastometry.Annals of laboratory medicine · 2024Article
- Preventing Blood Transfusion Errors: How Personal Digital Assistants Can Improve Patient Safety.Annals of laboratory medicine · 2024Article
- A systematic review and meta-analysis of blood transfusion rates during liver resection by country.Annals of surgical treatment and research · 2023Article
- Recent trends in perioperative blood transfusion during elective kidney transplantation.Korean journal of transplantation · 2023Article
- Investigation of blood group genotype prevalence in Korean population using large genomic databases.Scientific reports · 2023Article
- Transfusion thresholds: the need for a patient-centered approach in hematologic disorders that require chronic transfusion therapy.Blood research · 2023Review
- In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources.Stem cell research & therapy · 2023Article
- Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea.Osong public health and research perspectives · 2023Article
- Patient Blood Management and Its Role in Supporting Blood Supply.Journal of blood medicine · 2023Review
- Evaluation and management of platelet transfusion refractoriness.Blood research · 2022Review
- Exploring Blood Donation Challenges and Mobilization Mechanisms in North China During the COVID-19 Pandemic: A Qualitative Study.Risk management and healthcare policy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood is lifesaving; however, it can neither be limitlessly acquired nor artificially produced. The supply and use of blood, as an invaluable biological commodity, necessitate systematic and rational management under governmental guidance to ensure safe and reliable transfusions. Despite Korea's blood donation rate of 5.04%, which is higher than the 3.15% in high-income countries as reported by the WHO, the demand for blood exceeds the availability. This is due to the birthrate decline, dearth of young donors, and growing and aging recipient population. This review outlines the Korean blood management system, with a focus on blood service data from 2020, with the aim to delineate the current state of Korea's blood management system and the policies established to address the imminent blood shortage. Each policy is described in detail to provide helpful information for blood management services in other countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.